Component
IL-1beta-stimulated IL-2 production in mouse EL-4 cells
IL-1beta-stimulated IL-2 production in mouse EL-4 cells. Interpret through the linked study species, preparation, exposure and measured endpoint.
1 recorded relationships. Experimental role, claim status and evidence remain attached to each record.
How nutrients influence it
Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.
Other things that act on it
Enzymes, hormones, genes, and other components with a recorded effect. These are not nutrients, so they do not count toward the arrows above. Each finding names the chapter that recorded it.
How nutrients reach it in more than one step
Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.
Tracing routes…
What it does
Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.
What acts on it
Allicin pretreatment followed by washing enhanced subsequent IL-1beta-stimulated IL-2 production in mouse EL-4 cells.
Experimental context and source evidence
- evidence_access
- Primary full text available; selected claim-relevant methods, results, tables/figures and limitations reviewed. Supplemental proteome and all secondary findings are not exhaustively extracted.
- experimental_condition
- IL-1beta stimulation without allicin pretreatment pretreatment followed by wash · Allicin Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_condition
- IL-1beta stimulation without allicin pretreatment subsequent stimulation · Interleukin-1 beta / IL1B Condition belongs to the full experimental contrast; do not separate a joint intervention.
- experimental_contrast
- {"intervention": "Allicin pretreatment, wash, then IL-1beta stimulation", "comparator": "IL-1beta stimulation without allicin pretreatment", "endpoint": "Allicin pretreatment followed by washing enhanced subsequent IL-1beta-stimulated IL-2 production in mouse EL-4 cells.", "effect_direction": "increase", "combination": "joint", "conditions": [{"entity_slug": "allicin", "state": "pretreatment followed by wash"}, {"entity_slug": "il1b", "state": "subsequent stimulation"}]} Explicit extracted experimental comparison; source-derived draft.
- experimental_model
- Mouse EL-4: allicin 25 uM for 30 minutes, wash and fresh medium, then IL-1beta 0.5 ng/mL for 24 hours.
- interpretation_status
- Source-derived extraction of a fact-checked reference; access is explicit, not independent raw-data verification.
- limitations
- Sequential joint condition; not simultaneous exposure, basal IL-2 enhancement or human immune protection.
- plain_language
- Allicin pretreatment followed by washing enhanced subsequent IL-1beta-stimulated IL-2 production in mouse EL-4 cells.
- primary_references
- The human allicin-proteome: S-thioallylation of proteins by the garlic defence substance allicin and its biological effects. | 2019 | DOI 10.1016/j.freeradbiomed.2018.11.022 | PMID 30500420 | https://pubmed.ncbi.nlm.nih.gov/30500420/ | https://pmc.ncbi.nlm.nih.gov/articles/PMC6342545/ | https://doi.org/10.1016/j.freeradbiomed.2018.11.022
- source_locator
- Reviewed reference lines 45-45; exact primary location described in quoted passage where extracted.
Allicin: detailed mechanisms of action (reviewed 5 October 2026) · lines 45–45
Original AI-assisted review of primary studies and, where relevant, official regulatory records. Access level is retained per claim. Corrections, null results and unresolved questions remain explicit. Not publisher full text or independent replication. · supports · Mouse EL-4: allicin 25 uM for 30 minutes, wash and fresh medium, then IL-1beta 0.5 ng/mL for 24 hours. · source_derived_draft · unverified_draft
**Cytoskeleton and zinc.** In separate mouse-cell experiments in the same paper, 25–100 µM allicin disrupted L929 fibroblast actin organization after ten minutes. In EL-4 cells, 25 µM increased labile zinc at thirty minutes. For the IL-2 experiment, cells received 25 µM allicin for thirty minutes, were washed and supplied fresh medium, then received 0.5 ng/mL IL-1β for twenty-four hours; allicin pretreatment enhanced the stimulated IL-2 response. Detecting SOD1 modification in human Jurkat cells does not prove that SOD1 supplied the released zinc in mouse EL-4 cells. These outcomes do not establish improved human zinc nutrition or immune protection. [Gruhlke 2019](https://pmc.ncbi.nlm.nih.gov/articles/PMC6342545/)
Complete structured claim and evidence
The events it takes part in
A mechanism often involves more than two components. These are the full events, with every participant and its role.
Situations it appears in
Low-supply and faulty-machinery situations recorded in the chapters where this component plays a part.
In the sources
Preserved passages that mention this component, quoted exactly. Open one to read it in context.
Open hypotheses
Proposed ideas that involve this component. They are labeled as hypotheses and do not change any recorded statement.
This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.